Marc Forster Outbreak Drama 'Patient Zero' Scrapped at NBC

The Hollywood Reporter

NBC is calling time of death on Patient Zero.

The outbreak drama from Oscar winner Graham Moore (The Imitation Game) and director Marc Forster (World War Z) is no longer moving forward at the network, The Hollywood Reporter has confirmed.

Sky U.K. was co-developing the 10-part mini. The drama centered on a woman who, after she starts exhibiting mysterious symptoms, finds herself and her loved ones at the center of an epidemic with global consequences. Meanwhile, across the world, an FBI agent investigates a seemingly unrelated terrorist attack that leads him to the brink of madness. 

Moore, who won an Oscar for The Imitation Game, his first screenplay, created the drama. He was exec producing with Forster, who was also set to direct, Nora Grossman and Ido Ostrowsky. Jillian Kugler (Hand of God) was attached as a co-exec producer. The drama hailed from Fifty Fathoms Productions, Tiger Aspect Productions, 2DUX2 and Bristol Automotive in association with Endemol Shine Studios. NBC International Studios was handling distribution.

NBC ordered the project straight-to-series in May 2015. No cast had yet been announced for the series.

Patient Zero is one of several straight-to-series orders to hit a snag at NBC. Emerald City was ordered, then canceled and retooled, and picked up again. (It will air in early 2017). A revival of Coach was later abandoned.

After launching three new shows in the fall (This Is Us, The Good Place and Timeless), NBC is also bracing for a busy midseason slate that includes new dramas Taken, Chicago Justice, Emerald City, Midnight, Texas and The Blacklist: Redemption, as well as new comedies Powerless, Trial & Error, Marlon and Great News.

Although zombie dramas like The Walking Dead and its offshoot have remained popular, outbreak dramas have not had the same luck. The CW's Containment, an adaptation of the Belgian series Cordon, was canceled in May after one season.

The news was first reported by Radio Times.